New Phase 2 Paid Hepatitis C Clinical Trial | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Are There Shades of Grey in Hepatitis C Treatment Success?

Back to News Homepage
Next

Gilead's Sofosbuvir Gets High Marks for HIV/HCV Co-Infection

New Phase 2 Paid Hepatitis C Clinical Trial

The Editors at Hepatitis Central
September 17, 2012

Print this page

New Phase 2 Paid Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research in Central Florida; Accepting Male & Female Participants Age 18-70

The primary objectives of this study are to evaluate the 12-week safety, antiviral activity and tolerability of this new Hep C drug when given in combination with PEG and RIBA as measured by extended rapid virologic response.

For a detailed look at the description of the study, its objectives, inclusion criteria, as well as how to contact Avail Clinical Research and get started, click here: http://www.prweb.com/releases/trials/hepatitis-c/prweb9876722.htm

2 Comments
Share
Share
Previous

Are There Shades of Grey in Hepatitis C Treatment Success?

Back to News Homepage
Next

Gilead's Sofosbuvir Gets High Marks for HIV/HCV Co-Infection

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.